Farzaneh Salem
Associate Director, PB/PK Modelling GSK
Seminars
Saturday 17th January 2026
Predictive Power of PBPK Models to Guide CNS Oligonucleotide PK & Cellular Targeting
11:00 am
- Development and validation of PBPK models for predicting in vivo CNS exposure, distribution, and cellular engagement
- Characterizing cell-type–specific targeting in the CNS through consideration of biological barriers, cellular diversity, and molecular design
- Bridging preclinical insights to clinical application and identifying gaps
NEW DATA
